Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Reports 5th Consecutive Quarter of Revenue Growth

VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
August 10, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Closes Balance of $775,000 Equity Financing

VANCOUVER, British Columbia, Aug. 10, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Aequus Pharmaceuticals Inc. (TSX-V:...
August 09, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces Fully-subscribed $775,000 Equity Financing

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:...
July 31, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces Closing of $800,000 Equity Financing

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:...
July 24, 2018 18:00 ET | Source: Aequus Pharmaceuticals

Issuance of Stock Options

VANCOUVER, B.C., July 24, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), Aequus is pleased to announce it has granted incentive stock...
July 23, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces Proposed $800,000 Equity Financing To Next Edge Biotech Plus Fund

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 23, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc....
July 19, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces Expansion of Market Opportunity for its Long Acting Anti-Nausea Transdermal Patch

VANCOUVER, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”) is pleased to announce a recent expansion of the...
July 16, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada

VANCOUVER, British Columbia, July 16, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), is pleased to announce that it has agreed to new...
July 13, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus Announces New Independent Director to its Board

VANCOUVER, British Columbia, July 13, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
June 21, 2018 08:45 ET | Source: Aequus Pharmaceuticals

Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch

Key Highlights Aequus and Corium have expanded their relationship to include Aequus’ long-acting, transdermal patch for nausea and vomiting in pregnancy, AQS1303;Corium will utilize Corplex™, its...